首页> 美国卫生研究院文献>other >The IMAAGEN Study: Effect of Abiraterone Acetate and Prednisone on Prostate-Specific Antigen and Radiographic Disease Progression in Patients with Non-Metastatic Castration-Resistant Prostate Cancer

【2h】

The IMAAGEN Study: Effect of Abiraterone Acetate and Prednisone on Prostate-Specific Antigen and Radiographic Disease Progression in Patients with Non-Metastatic Castration-Resistant Prostate Cancer

机译：IMAAGEN研究：醋酸阿比特龙和泼尼松对非转移性去势抵抗性前列腺癌患者前列腺特异性抗原和放射学疾病进展的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose:To evaluate >the use of abiraterone acetate (1000 mg) plus prednisone (5mg) [AA+P] in patients with high-risk non-metastatic castration resistant prostate cancer (nmCRPC).

机译：目的：评估在高风险，非转移性去势抵抗性前列腺癌（nmCRPC）患者中使用醋酸阿比特龙（1000 mg）加泼尼松（5mg）[AA + P]的效果。

著录项

期刊名称 other
作者
Charles J. Ryan; E. David Crawford; Neal D. Shore; Willie Underwood III; Mary-Ellen Taplin; Anil Londhe; Peter St. John Francis; Jennifer Phillips; Tracy McGowan; Philip W. Kantoff;
展开▼
作者单位

展开▼
年(卷),期 -1(200),2
年度 -1
页码 344–352
总页数 17
原文格式 PDF
正文语种
中图分类
关键词
abiraterone acetate prostatic neoplasms;

机译：乙酸阿比特龙酯;前列腺肿瘤;

相似文献

外文文献
中文文献
专利

1. The IMAAGEN Study: Effect of Abiraterone Acetate and Prednisone on Prostate Specific Antigen and Radiographic Disease Progression in Patients with Nonmetastatic Castration Resistant Prostate Cancer [J] . Charles J. Ryan, E. David Crawford, Neal D. Shore, The Journal of Urology . 2018,第2期

机译：Imaagen研究：Abiraaterone醋酸盐和泼尼松对非更换阉割前列腺癌患者前列腺特异性抗原和放射线疾病进展的影响
2. The Phase 3 COU-AA-302 Study of Abiraterone Acetate Plus Prednisone in Men with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: Stratified Analysis Based on Pain, Prostate-specific Antigen, and Gleason Score [J] . Miller Kurt, Carles Joan, Gschwend Juergen E., European urology . 2018,第1期

机译：第3阶段CO-AA-302研究Abiraaterone醋酸盐加入泼尼松在细胞化疗 - 幼稚转移性阉割前列腺癌中的研究：基于疼痛，前列腺特异性抗原和Gleason评分的分层分析
3. Independent association between time to prostate-specific antigen (PSA) nadir and PSA progression-free survival in patients with docetaxel-naive, metastatic castration-resistant prostate cancer receiving abiraterone acetate, but not enzalutamide [J] . Miyake Hideaki, Hara Takuto, Tamura Keita, Urologic oncology . 2017,第6期

机译：在多西紫杉醇 - 幼稚园，转移性阉割的前列腺癌患者接受醋酸盐的患者的患者的患者中，抗原抗原（PSA）Nadir和PSA无进展生存之间的独立关联。
4. Analysis of glycoforms of urinary prostate-specific antigen of prostate cancer and benign prostate hyperplasia samples [C] . Chun-Jen Hsiao, Tzong-Shin Tzai, Chein-Hung Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：前列腺癌和良性前列腺增生样品的尿道前列腺特异性抗原糖族分析
5. Studies on human prostate-specific antigen as a tumor antigen for the immunotherapy of prostate cancer in a mouse model. [D] . Willis, Richard Allen. 2002

机译：人类前列腺特异性抗原作为一种肿瘤抗原的免疫模型在小鼠模型中的研究。
6. Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone [O] . Zhenyu Yang, Yuchao Ni, Diwei Zhao, 2021

机译：从泼尼松到地塞米松的皮质类固醇切换转移性阉割前列腺癌癌症患者ABIRATERONE加入泼尼松生化进展
7. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer [O] . Rescigno Pasquale, Lorente David, Bianchini Diletta, 2016

机译：转移性去势抵抗性前列腺癌患者接受醋酸阿比特龙治疗4周后前列腺特异性抗原下降和总体生存率

The IMAAGEN Study: Effect of Abiraterone Acetate and Prednisone on Prostate-Specific Antigen and Radiographic Disease Progression in Patients with Non-Metastatic Castration-Resistant Prostate Cancer

摘要

著录项

相似文献

相关主题

期刊订阅